Centaurus Financial’s Strata Skin Sciences SSKN Stock Holding History

Centaurus Financial’s Portfolio SSKN Stock Details SSKN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-5	Closed	–	–	1844
2018 Q2	$0	Buy	+5	New	+$82	﹤0.01%	2373

Other funds holding SSKN

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Centaurus Financial's SSKN Position: Q3 2018 in Review

Centaurus Financial sold out of Strata Skin Sciences (SSKN) in Q3 2018, closing a stake of 5 shares.

Centaurus Financial first reported a position in SSKN in Q2 2018 and held it in 1 quarter. The position peaked at $0 in Q2 2018. 30 funds tracked by Wall St. Rank hold SSKN as of Q3 2018.

Centaurus Financial reported no remaining Strata Skin Sciences position as of Q3 2018 after selling out during the quarter.
Centaurus Financial sold 5 Strata Skin Sciences shares in Q3 2018.
Centaurus Financial first reported a position in Strata Skin Sciences in Q2 2018 and held it in 1 quarter.
Centaurus Financial's Strata Skin Sciences position peaked at $0 in Q2 2018.
30 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q3 2018.

Based on Centaurus Financial's 13F filing for Q3 2018, filed 5 Nov 2018.